Showing results (121-130 of 212) with videos related to
Sort By:
Pageof 22
Investigational New Drugs|December 18, 2012
Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trialsMitesh J Borad, Arundhati D Soman, Martin Benjamin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2014
A phase I dose-finding study of the novel Toll-like receptor 8 agonist VTX-2337 in adult subjects with advanced solid tumors or lymphomaDonald W Northfelt, Ramesh K Ramanathan, Peter A Cohen, et al.The Oncologist|October 22, 2024
Hand therapy interventions for the prevention of chemotherapy-induced peripheral neuropathy of the hands in patients with pancreatic cancerGayle S Jameson, Cynthia Cooper, Courtney Snyder, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 9, 2017
The National Cancer Institute R25 Cancer Education Grants Program: A Workshop ReportJeannette F Korczak, Davyd W Chung, Erica Rosemond, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
Pharmacokinetics of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors: the role of alpha-1-acid glycoprotein bindingRichard A Graham, Bert L Lum, Sravanthi Cheeti, et al.Dermatology and Therapy|September 2, 2015
A Qualitative Comparison of Symptoms and Impact of Varying Stages of Basal Cell CarcinomaAnna W Steenrod, Emily Nash Smyth, Elizabeth N Bush, et al.Oncogenesis|November 10, 2020
Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblastsPawan Noel, Shaimaa Hussein, Serina Ng, et al.Cancer|January 20, 2011
Patient willingness to undergo pharmacodynamic and pharmacokinetic tests in early phase oncology trialsRaoul Tibes, Barbara F Piper, Jessica A Smith, et al.Annals of Surgery|December 14, 2011
Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancerMichael J Demeure, Elizabeth Stephan, Shripad Sinari, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2014
Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer typeZoran Gatalica, Carrie Snyder, Todd Maney, et al.Pageof 22